The National Cancer Institute estimates there will be 226,870 women diagnosed with breast cancer in the United States in 2012. There are now estimated to be 2.6 million breast cancer survivors. Early detection and treatment of breast is the best current strategy for reducing the morbidity and mortality of the disease. An ideal screening method would be one that is sensitive enough to detect breast cancer early, specific enough to differentiate malignant from benign lesions, easily accessible to the general public, financially feasible, and unlikely to cause harm to the patient.
Currently, mammograms are the only U.S. Food and Drug Administration (FDA)–approved standalone diagnostic tool for screening use in the general population. However, like any imaging procedure, mammograms have limitations, including fairly low sensitivity, particularly in those with dense breasts. There is also a fairly high false positive rate, with up to 50% of women getting annual mammograms for 10 years, which leads to unnecessary biopsies of benign lesions in 25% of these women. Lastly, there is the small but measurable risk from the gamma radiation when used repeatedly, particularly in those of a younger age.
Modern whole Body Thermography is a non-invasive “early detection” system that accurately assesses organ and body malfunctions by identifying “signatures” of diseases.
Click below tofind out more
Do an assessment and discover the truth about your health status
Call 63236652 to make an appointment today.